The Latest Breaking News from Alzheimer Disease

The Food and Drug Administration granted accelerated approval of a disease-modifying treatment that could potentially give some patients with Alzheimer's disease something they haven't had before: a medication that may slow the decline of memory and thinking.

A team of neuroscientists led by a University of Pittsburgh School of Medicine researcher developed a blood test to detect a new marker of Alzheimer's disease neurodegeneration. Read on for details:

Bottlenose dolphin, a long-finned pilot whale and a third species found to have markers of the degenerative disease

The findings might help explain why some species get stranded, researchers say.

A new study shows four animals from different dolphin species have some of the brain changes associated with human Alzheimer’s disease

As the population ages, the number of people with neurodegenerative diseases, such as Alzheimer’s disease, increases. Approximately 75,000 Canadians are diagnosed with Alzheimer’s disease each year and experience a decline in their cognitive abilities. The ordeal usually lasts for several years while their family members watch helplessly.

A new study found a link between higher concentrations of Vitamin D and improved cognition in aging people.

When actor Chris Hemsworth, aka Thor, God of Thunder, agreed to host a National Geographic series about extending the human life span, he didn’t expect to discover a genetic risk of his own. But that’s what happened as Hemsworth revealed on an episode of “Limitless” that he carries a common…

Many neurodegenerative diseases, or conditions that result from the loss of function or death of brain cells, remain largely untreatable. Most available treatments target just one of the multiple processes that can lead to neurodegeneration, which may not be effective in completely addressing disease symptoms or progress, if at all.